Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers

A Phase 2b, Randomized, Double-blind, Active-controlled Study of Single Dose CVXGA Intranasal COVID-19 Vaccine in Adults

ClinicalTrials.gov ID: NCT06742281

Public ClinicalTrials.gov record NCT06742281. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 6:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b, Randomized, Double-blind, Active-controlled Study of Single Dose CVXGA (CVXGA50) Intranasal COVID-19 Vaccine in Adults

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this trial is to assess the safety and relative efficacy of CVXGA (CVXGA50), a KP.2 containing vaccine, compared to COMIRNATY® (COVID-19 Vaccine, mRNA; 2024-2025 Formula), a currently approved COVID-19 vaccine in the prevention of symptomatic, RT-PCR-confirmed SARS-CoV-2 infection. The trial will enroll up to 434 healthy participants.

Study identification

NCT ID
NCT06742281
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
CyanVac LLC
Industry
Enrollment
432 participants

Conditions and interventions

Conditions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years to 100 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 5, 2024 (Actual)
Primary completion
Jun 15, 2026 (Actual)
Completion
Jun 15, 2026 (Actual)
Last update posted
Oct 13, 2026

2024 – 2026

United States locations

U.S. sites
55
U.S. states
22
U.S. cities
47
Facility City State ZIP Site status
Pinnacle Research Group, LLC Anniston Alabama 36207 —
Velocity Clinical Research, Phoenix Phoenix Arizona 85006 —
Velocity Clinical Research, Chula Vista Chula Vista California 91911 —
Velocity Clinical Research, San Diego La Mesa California 91942 —
Imax Clinical Trials La Palma California 90623 —
Artemis Institute for Clinical Research Riverside California 92503 —
Clinical Innovations Inc. dba CITrials Riverside California 92506 —
Avacare Sacramento California 95864 —
Collaborative Neuroscience Research, LLC Torrance California 90504 —
Velocity Clinical Research, Washington DC Washington D.C. District of Columbia 20016 —
Velocity Clinical Research, Hallandale Beach Hallandale Florida 33009 —
Homestead Associates in Research, Inc Homestead Florida 33033 —
Biscayne Clinical Research North Miami Beach Florida 33169 —
Headlands Research Orlando Orlando Florida 32819 —
Best Choice Medical and Research Service Pembroke Pines Florida 33024 —
Forcare Clinical Research Tampa Florida 33613 —
Guardian Angel Research Center Tampa Florida 33614 —
Lifeline Primary Care/Avacare Lilburn Georgia 30047 —
Velocity Clinical Research, Savannah Savannah Georgia 31406 —
Clinical Research Atlanta Stockbridge Georgia 30281 —
Velocity Clinical Research, Boise Meridian Idaho 83642 —
Velocity Clinical Research, Sioux City Sioux City Iowa 51106 —
Velocity Clinical Research, Covington Covington Louisiana 70433 —
Velocity Clinical Research, Lafayette Lafayette Louisiana 70508 —
Velocity Clinical Research, New Orleans New Orleans Louisiana 70119 —
CBH Health Gaithersburg Maryland 20877 —
Advanced Primary and Geriatric Care/Avacare Rockville Maryland 20850 —
Velocity Clinical Research, Rockville Rockville Maryland 20854 —
DM Clinical Research Southfield Michigan 48076 —
Velocity Clinical Research - Norfolk Norfolk Nebraska 68701 —
Quality Clinical Research, Inc Omaha Nebraska 68114 —
Velocity Clinical Research, Omaha Omaha Nebraska 68134 —
DM Clinical Research Jersey City New Jersey 07306 —
Velocity Clinical Research, Binghamton Binghamton New York 13905 —
Rochester Clinical Research Rochester New York 14609 —
Trial Management Associates, LLC Wilmington North Carolina 28403 —
Velocity Clinical Research, Cleveland Beachwood Ohio 44122 —
Velocity Clinical Research, Mt. Auburn Cincinnati Ohio 45219 —
Velocity Clinical Research, Springdale Cincinnati Ohio 45246 —
Tekton Research, LLC Yukon Oklahoma 73099 —
DM Clinical Research Philadelphia Pennsylvania 19107 —
Velocity Clinical Research, Anderson Anderson South Carolina 29621 —
Velocity Clinical Research Gaffney Gaffney South Carolina 29340 —
Avacare Austin Texas 78705 —
Tekton Research, LLC Austin Texas 78745 —
Velocity Clinical Research, Austin Austin Texas 78759 —
Pan American Clinical Research, LLC Brownsville Texas 78520 —
Avacare Fort Worth Texas 76135 —
DM Clinical Research Houston Texas 77065 —
DM Clinical Research Houston Texas 77081 —
Avacare San Angelo Texas 76904 —
Tekton Research, LLC San Antonio Texas 78229 —
Velocity Clinical Research, Salt Lake City West Jordan Utah 84088 —
Clinical Research Partners LLC Richmond Virginia 23226 —
Velocity Clinical Research, Suffolk Suffolk Virginia 23435 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06742281, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 13, 2026 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06742281 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →